Sumitomo Mitsui DS Asset Management Company Ltd Purchases 27,943 Shares of Colgate-Palmolive Company $CL

Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in shares of Colgate-Palmolive Company (NYSE:CL) by 17.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 188,496 shares of the company’s stock after acquiring an additional 27,943 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Colgate-Palmolive were worth $15,068,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in CL. Westside Investment Management Inc. lifted its stake in Colgate-Palmolive by 85.5% during the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after purchasing an additional 130 shares during the last quarter. Vermillion & White Wealth Management Group LLC raised its holdings in shares of Colgate-Palmolive by 86.1% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after buying an additional 155 shares in the last quarter. MTM Investment Management LLC bought a new stake in shares of Colgate-Palmolive during the 2nd quarter worth $39,000. Atticus Wealth Management LLC boosted its stake in Colgate-Palmolive by 156.8% in the second quarter. Atticus Wealth Management LLC now owns 488 shares of the company’s stock valued at $44,000 after buying an additional 298 shares in the last quarter. Finally, Twin Peaks Wealth Advisors LLC bought a new position in Colgate-Palmolive in the second quarter valued at about $44,000. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Price Performance

CL stock opened at $81.44 on Friday. The company has a market capitalization of $65.64 billion, a P/E ratio of 22.81, a PEG ratio of 5.52 and a beta of 0.30. The company has a fifty day moving average price of $78.71 and a 200-day moving average price of $81.95. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.60 and a current ratio of 0.93. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $100.18.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a return on equity of 333.39% and a net margin of 14.47%.Colgate-Palmolive’s quarterly revenue was up 1.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.91 earnings per share. As a group, equities analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date is Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 58.26%.

Wall Street Analysts Forecast Growth

CL has been the subject of a number of research reports. Raymond James Financial dropped their target price on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a report on Monday, October 20th. The Goldman Sachs Group dropped their price objective on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a research note on Thursday, October 2nd. Argus reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research note on Thursday, December 11th. Bank of America dropped their price target on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Finally, Morgan Stanley cut their price objective on Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating on the stock in a report on Monday, November 3rd. Eleven equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $88.19.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.